Ticker Scorecard - STOK Basics Company: Stoke Therapeutics, Inc. IPO Date: June 17, 2019 Sector: Healthcare Industry: Biotech Market Cap: $441.21M Activated in VL: True Average Daily Range Avg Daily Range: $0.68 | 3.33% Avg Daily Range (30 D): $0.41 | 3.98% Avg Daily Range (90 D): $0.32 | 2.81% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): .72M Avg Daily Volume (90 D): .49M Trade Size Avg Trade Size (Sh.): 81 Avg Trade Size (Sh.) (30 D): 79 Avg Trade Size (Sh.) (90 D): 72 Institutional Trades Total Inst.Trades: 998 Avg Inst. Trade: $1.9M Avg Inst. Trade (30 D): $1.24M Avg Inst. Trade (90 D): $1.5M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.49M Avg Closing Trade (30 D): $.98M Avg Closing Trade (90 D): $1.15M Avg Closing Volume: 84.95K     News Jun 28, 2024 @ 4:01 PM A Closer Look at 5 Analyst Recommendations For Sto... Source: Benzinga Insights May 6, 2024 @ 3:01 PM Analyst Expectations For Stoke Therapeutics's Futu... Source: Benzinga Insights May 6, 2024 @ 12:05 PM Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, T... Source: Zacks Equity Research Apr 29, 2024 @ 2:00 PM Earnings Preview: Axsome Therapeutics (AXSM) Q1 Ea... Source: Zacks Equity Research Apr 25, 2024 @ 2:01 PM Earnings Preview: Stoke Therapeutics, Inc. (STOK) ... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.09 $-.47 $-.46 Diluted EPS $-2.09 $-.47 $-.46 Revenue $ 16.74M $ 4.89M $ 4.83M Gross Profit $ $ $ Net Income / Loss $ -105.46M $ -26.43M $ -25.7M Operating Income / Loss $ -117.3M $ -30M $ -29.34M Cost of Revenue $ $ $ Net Cash Flow $ -39.96M $ -43.46M $ 14.9M PE Ratio     Splits Jun 06, 2019:   99:10